![Michael Giuliani](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Michael Giuliani
Keine laufenden Positionen mehr
Vermögen: 930 387 $ am 31.05.2024
Profil
Michael J.
Giuliani's former job positions include Director-Clinical Research & Development at Wyeth LLC, Senior Director-Clinical Neuroscience at Merck & Co., Inc., Independent Director at MiMedx Group, Inc., Vice President-Research & Development at Mallinckrodt Plc, Chief Medical Officer & EVP-Product Development at Xanodyne Pharmaceuticals, Inc., and Vice President-Research & Development at Covidien Unlimited Co. He also served as a Member of the American Association of Neurological Surgeons and Chief Resident at The Cleveland Clinic Foundation.
Dr. Giuliani obtained an undergraduate degree from Tulane University (Louisiana) and a doctorate degree from The Ohio State University.
Bekannte Unternehmensbeteiligungen
Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
---|---|---|---|---|
MIMEDX GROUP, INC.
0,09% | 08.04.2024 | 130 124 ( 0,09% ) | 930 387 $ | 31.05.2024 |
Ehemalige bekannte Positionen von Michael Giuliani
Unternehmen | Position | Ende |
---|---|---|
MIMEDX GROUP, INC. | Direktor/Vorstandsmitglied | 05.06.2024 |
MALLINCKRODT PLC | Technik-/Wissenschafts-/F&E-Leiter | 01.06.2016 |
Xanodyne Pharmaceuticals, Inc.
![]() Xanodyne Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Xanodyne Pharmaceuticals, Inc. operates as an integrated specialty pharmaceutical company with both development and commercial capabilities focused on pain management and women's healthcare. It markets a portfolio of prescription pharmaceuticals and a line of prenatal vitamins. The firm's product candidates include XP12B, a tranexamic acid modified release oral tablet for the reduction of menstrual blood loss in women, who suffer from menorrhagia or excessive menstrual bleeding; and XP20B is a combination propoxyphene and acetaminophen modified release oral tablet for the treatment of mild to moderate pain. The company was founded by Gilbert R. Gonzales and Roger Dale Griggs in May 2001 and is headquartered in Newport, KY. | Technik-/Wissenschafts-/F&E-Leiter | 01.10.2007 |
Covidien Unlimited Co.
![]() Covidien Unlimited Co. Medical SpecialtiesHealth Technology Covidien Unlimited Co. engages in the development, manufacture, and sale of healthcare products for use in clinical and home settings. It operates through Medical Devices and U.S. Medical Supplies segments. The Medical Devices segment involves in the distribution of surgical solutions, peripheral vascular and neurovascular therapies, patient monitoring products, and airway and ventilation products. The U.S. Medical Supplies segment includes marketing of nursing care, medical surgical, SharpSafety brand, and original equipment manufacturer (OEM) products. The company was founded in 1967 and is headquartered in Dublin, Ireland. | Technik-/Wissenschafts-/F&E-Leiter | - |
The Cleveland Clinic Foundation
![]() The Cleveland Clinic Foundation Medical/Nursing ServicesHealth Services The Cleveland Clinic Foundation operates as a non-profit academic, research, and medical center. It offers clinic and hospital care with research and education services. The company was founded by Charles Posternack, George W. Crile, Frank E. Bunts, William E. Lower and John Phillips on February,5 1921 and is headquartered in Cleveland, OH. | Corporate Officer/Principal | - |
Ausbildung von Michael Giuliani
Tulane University (Louisiana) | Undergraduate Degree |
The Ohio State University | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Börsennotierte Unternehmen | 3 |
---|---|
MERCK & CO., INC. | Health Technology |
MIMEDX GROUP, INC. | Health Technology |
MALLINCKRODT PLC | Health Technology |
Private Unternehmen | 5 |
---|---|
Xanodyne Pharmaceuticals, Inc.
![]() Xanodyne Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Xanodyne Pharmaceuticals, Inc. operates as an integrated specialty pharmaceutical company with both development and commercial capabilities focused on pain management and women's healthcare. It markets a portfolio of prescription pharmaceuticals and a line of prenatal vitamins. The firm's product candidates include XP12B, a tranexamic acid modified release oral tablet for the reduction of menstrual blood loss in women, who suffer from menorrhagia or excessive menstrual bleeding; and XP20B is a combination propoxyphene and acetaminophen modified release oral tablet for the treatment of mild to moderate pain. The company was founded by Gilbert R. Gonzales and Roger Dale Griggs in May 2001 and is headquartered in Newport, KY. | Health Technology |
American Association of Neurological Surgeons
![]() American Association of Neurological Surgeons Miscellaneous Commercial ServicesCommercial Services The American Association of Neurological Surgeons is an organization that provides resources and tools for neurosurgeons and trainees in the field. The organization is based in Rolling Meadows, IL. The company's website offers information on membership benefits, education and training opportunities, publications, patient resources, advocacy efforts, and career opportunities. | Commercial Services |
Wyeth Corp.
![]() Wyeth Corp. Pharmaceuticals: MajorHealth Technology Wyeth LLC develops, manufactures, and distributes pharmaceuticals and biological substances. The company was founded in 1926 and is headquartered in Madison, NJ. | Health Technology |
The Cleveland Clinic Foundation
![]() The Cleveland Clinic Foundation Medical/Nursing ServicesHealth Services The Cleveland Clinic Foundation operates as a non-profit academic, research, and medical center. It offers clinic and hospital care with research and education services. The company was founded by Charles Posternack, George W. Crile, Frank E. Bunts, William E. Lower and John Phillips on February,5 1921 and is headquartered in Cleveland, OH. | Health Services |
Covidien Unlimited Co.
![]() Covidien Unlimited Co. Medical SpecialtiesHealth Technology Covidien Unlimited Co. engages in the development, manufacture, and sale of healthcare products for use in clinical and home settings. It operates through Medical Devices and U.S. Medical Supplies segments. The Medical Devices segment involves in the distribution of surgical solutions, peripheral vascular and neurovascular therapies, patient monitoring products, and airway and ventilation products. The U.S. Medical Supplies segment includes marketing of nursing care, medical surgical, SharpSafety brand, and original equipment manufacturer (OEM) products. The company was founded in 1967 and is headquartered in Dublin, Ireland. | Health Technology |